Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated about 9 hours ago
Double shot of Vistagen’s anxiety nasal spray can’t beat placebo in ph. 2 trial
about 9 hours ago
Following a string of clinical setbacks, Vistagen’s nasal spray for social anxiety...
PacBio CEO steps down as Q2 loss widens
about 9 hours ago
PacBio has promoted an internal veteran to CEO after Christian Henry stepped...
Tarsus pays $450M for Alkeus and its phase 3-stage retinal disease drug
about 9 hours ago
Tarsus Pharmaceuticals is fronting $450 million to acquire Alkeus Pharmaceuticals for its...
BioVie’s stock sinks 50% as company uses composite endpoint to make case for Parkinson’s program
about 10 hours ago
BioVie has hailed phase 2 data as evidence that bezisterim could represent...
Braveheart charges past expectations with $382.5M IPO to fund cardio drug from Hengrui
about 11 hours ago
Braveheart Bio has overcome its own IPO expectations, rallying $382.5 million in...
Actimed gets back rights to wasting disease drug, ending $126M deal with Faraday
about 11 hours ago
Actimed Therapeutics has brought the full rights to its wasting disease drug...
‘Greg, you’ve got to bring back this platform’: How LifeMine won over Gates and Bezos for $188M series E
about 13 hours ago
A little over a year ago, LifeMine Therapeutics laid off staff and...
Context scraps bispecific T-cell engager program to extend cash runway deeper into 2027
about 13 hours ago
Context Therapeutics has stopped development of the bispecific T-cell engager CT-95, freeing...
Narcan maker Emergent BioSolutions eliminates top R&D role in sweeping restructuring
about 23 hours ago
Two and a half years into his tenure as Emergent BioSolutions CEO...
Fecal transplant increases tolerance to peanuts sixfold in small food allergy trial
1 day ago
Fecal transplants can increase tolerance to peanuts sixfold in people with food...
Sanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’
1 day ago
Sanofi halted a phase 2 trial testing a monoclonal antibody, SAR445399, in...
Lilly drops another gene therapy trial from $1B Prevail buyout
1 day ago
Eli Lilly has axed another trial of a gene therapy acquired in...